Neosec
Last updated: May 10, 2026
Neosec was an Israeli API security startup whose technology now appears as part of Akamai's API Security product. It focused on discovering shadow APIs, baselining API behavior, and detecting abuse, data leakage, and business-logic attacks that perimeter tools often miss.
Visit WebsiteCompany Overview
Neosec built around the idea that APIs are not just a transport layer but a living attack surface with their own behavioral patterns, data flows, and abuse modes. Instead of relying only on signatures or gateway policy, the product discovered APIs automatically, profiled normal request behavior, and looked for deviations that could indicate credential abuse, scraping, business-logic exploitation, or sensitive-data exposure. That approach mapped well to enterprises whose APIs were growing faster than their security inventories.
The current official web presence now resolves to Akamai's API Security product page, which describes capabilities such as discovering shadow, zombie, and AI-related APIs; identifying OWASP API Top 10 issues; testing APIs in CI/CD; and monitoring abuse with real-time analytics. That makes the Neosec asset best understood as an acquired capability that helped broaden Akamai's API security stack rather than as a standalone startup with an independent product roadmap. The underlying market need remains real: APIs are multiplying across mobile, SaaS, partner integration, GenAI workflows, and internal microservices, and the security gap is often visibility, context, and runtime detection.
Commercially, this sits in a crowded but durable security segment where buyers want continuous API inventory, attack detection, and pre-production testing. The category has consolidated quickly, with larger security vendors folding API security into broader platforms and point vendors racing to prove differentiation through behavioral analytics, testing depth, or platform integrations. For Neosec, the main evidence of market validation is not just the product thesis but the acquisition by Akamai, which suggests the technology was useful enough to absorb into a major security distribution channel.
From a defense and national-security angle, the relevance is substantive but indirect: the same behaviors that matter in commercial API estates also matter in government, defense, and critical-infrastructure environments that rely on mobile apps, cloud services, partner APIs, and inter-agency integrations. Visibility into shadow APIs, anomalous access, and data exfiltration risk is useful in zero-trust architectures, but the product does not look defense-specific. Its dual-use value comes from applying commercial API telemetry and abuse detection to sensitive enterprise and public-sector environments.
Dual-Use Assessment
API discovery, behavioral anomaly detection, and sensitive-data monitoring are directly useful in commercial enterprises and in government or defense environments that depend on cloud APIs, partner integrations, and mobile access. The dual-use thesis is credible, but it is an adjacency to broader cybersecurity rather than a defense-native capability.
Strategic Fit Assessment
This is not an independent startup for direct diligence because Neosec has already been acquired and folded into Akamai's product line. The underlying technology was strategically validated, but any thesis here is now about platform integration and acquisition precedent rather than new venture upside.
Strategic Value to U.S.-Israel Alliance
API security remains strategically important because so much sensitive business and mission traffic now flows through APIs instead of traditional web sessions. Technology that can inventory, test, and monitor APIs for abuse has clear relevance for critical infrastructure, government systems, and defense-adjacent digital transformation.
Key Technologies
- Automated API discovery and inventory for shadow, zombie, and AI-related endpoints
- Behavioral baselining and anomaly detection for API traffic
- Business-logic abuse detection and suspicious sequence analysis
- Sensitive-data and data-exposure monitoring across API responses
- Pre-production API testing and OWASP API Top 10 coverage
- CI/CD and workflow integrations for continuous API governance
Use Cases & Applications
- Enterprise-wide API inventory and shadow API discovery
- Runtime detection of API abuse, scraping, and credential-stuffing patterns
- Business-logic testing before APIs reach production
- Monitoring for data leakage, misconfigurations, and exposed sensitive fields
- Securing GenAI, LLM, and MCP-related API integrations
- Supporting zero-trust monitoring in government and defense-adjacent environments
- Prioritizing API remediation work for security and engineering teams
Sources and verification
This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile.
Public sources
The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.
- Official website Primary public reference for company identity, positioning, and current web presence.
- Profile update timestamp Last updated in the Claw & Talon database on May 10, 2026.
Investor Lens
What this entry is
Acquired asset
Why it may matter
Neosec may matter as a Cybersecurity entry with not currently an investable standalone company for Israeli technology research.
How an independent investor should read this
Not currently an investable standalone company. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.
Evidence to verify
- Verify current status
- Verify technical claims
- Verify regulatory/export-control issues
Main investor questions
- Is this entry a benchmark, buyer, ecosystem node, acquired asset, or strategic reference rather than a live startup opportunity?
- What does this reference clarify about buyers, sector structure, public-market context, or strategic demand?
- Does the dual-use claim map to actual commercial and government/defense/resilience buyer evidence?
- What evidence would change the thesis or show that the profile is stale?
What not to infer
- Inclusion does not imply endorsement.
- Inclusion does not imply allocation availability or current fundraising.
- Scores do not indicate investment suitability or expected returns.
- Strategic importance does not automatically imply venture return potential.
Diligence questions
- What evidence verifies Neosec's current customer traction, deployment status, and revenue concentration?
- Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
- Where does the product create real defense, intelligence, critical-infrastructure, or emergency-response value beyond ordinary commercial adoption?
- How does the platform integrate into existing SOC, cloud, identity, or compliance workflows without adding operational burden?
- Is the company a live venture opportunity, a mature strategic reference, an acquired asset, or primarily a market-mapping entry?
Related sector
See the Cybersecurity sector page for market context, related subcategories, and other Israeli companies in this part of the database.
Related companies
Need a diligence readout?
Use the profile and related checklists as a starting point. If the decision needs more context, request a company screen, founder-call prep, diligence memo, or sector readout.